Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.
Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedAn administrative update adds Revision: v3.4.2 and removes older notices (lapse-in-funding notice and v3.4.1 reference). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check11 days agoChange DetectedA government funding notice was added and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%
- Check19 days agoChange DetectedThe new version adds a Show glossary option and green/red highlights for additions and deletions, and updates the Revision label to v3.4.0; the previous v3.3.4 entry is removed.SummaryDifference0.5%
- Check26 days agoChange DetectedA new 'Study Status' entry was added on 2026-01-13 and an entry from 2026-01-12 was removed in the record history.SummaryDifference0.2%
- Check33 days agoChange DetectedOn 2026-01-12, Eligibility and Study Status were added to the record history. A deletion occurred on 2025-12-17.SummaryDifference0.3%
- Check54 days agoChange DetectedVersion 3.3.3 updates the record to include full core content sections (Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Study Status, Study Identification); a related IMvigor011 study reference was removed in a prior revision.SummaryDifference0.7%
Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.